Evans Daron

Average Profitability
44.9%
Insider Buys Quantity
38
Insider Buys Sum
$647,819.90
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Evans Daron

According to the SEC Form 4 filings, Evans Daron, being in a position of

  1. CFO at Rezolute, Inc.,
    оver the last 12 months, has bought 159851 share for $363,566, and sold 0 shares,
    over all time since 2024-02-16, has bought 159851 share for $363,566, and sold 0 shares.

The largest purchase of all time was on 2024-06-14 and amounted to 40000 shares of Rezolute, Inc. for $161,568.

Biography of Evans Daron

No biography is available at this moment.

2024-06-14PurchaseRezolute, Inc.
RZLT
CFO
40,000
0.0754%
$4.04$161,568+18.99%
2024-05-29PurchaseRezolute, Inc.
RZLT
CFO
451
0.001%
$3.50$1,579+13.8%
2024-05-24PurchaseRezolute, Inc.
RZLT
CFO
2,942
0.0077%
$3.23$9,503+32.02%
2024-05-23PurchaseRezolute, Inc.
RZLT
CFO
58
0.0001%
$2.85$165+54.1%
2024-03-15PurchaseRezolute, Inc.
RZLT
CFO
20,000
0.048%
$1.69$33,830+140.17%
2024-03-08PurchaseRezolute, Inc.
RZLT
CFO
50,000
0.1293%
$1.93$96,345+124.21%
2024-02-16PurchaseRezolute, Inc.
RZLT
CFO
46,400
0.1132%
$1.31$60,576+196.3%
2020-03-12PurchaseNephros, Inc.
NEPH
President and CEO
2,500
0.0298%
$6.65$16,625+15.79%
2020-03-05PurchaseNephros, Inc.
NEPH
President and CEO
2,500
0.0298%
$8.44$21,109-9.03%
2019-11-18PurchaseNephros, Inc.
NEPH
President and CEO
1,000
0.0138%
$8.35$8,350-3.11%
2019-08-22PurchaseNephros, Inc.
NEPH
President and CEO
2,000
0.0262%
$6.92$13,845+19.71%
2019-06-14PurchaseNephros, Inc.
NEPH
President and CEO
43,172
0.0625%
$0.60$25,761+45.16%
2018-04-10PurchaseNephros, Inc.
NEPH
President and CEO
79,000
0.1497%
$0.45$35,550+55.26%
2017-09-06PurchaseNephros, Inc.
NEPH
President and CEO
28,000
0.0525%
$0.24$6,818+108.33%
2017-09-05PurchaseNephros, Inc.
NEPH
President and CEO
1,580
0.0029%
$0.23$371+104.17%
2017-08-22PurchaseNephros, Inc.
NEPH
President and CEO
4,000
0.008%
$0.25$1,000+108.7%
2017-08-11PurchaseNephros, Inc.
NEPH
President and CEO
70,000
0.1201%
$0.26$18,200+71.43%
2017-06-12PurchaseNephros, Inc.
NEPH
President and CEO
3,961
0.0066%
$0.26$1,030+73.08%
2017-06-09PurchaseNephros, Inc.
NEPH
President and CEO
17,500
0.0333%
$0.26$4,550+73.08%
2017-05-19PurchaseNephros, Inc.
NEPH
President and CEO
7,500
0.0136%
$0.26$1,913+73.08%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.